Skip to main content
MedPathMedPath Home
Clinical Trials/NCT07351812
NCT07351812
Recruiting
Not Applicable

Evaluation of Two Treatment Modalities for Myogenous Temporomandibular Disorders: A Randomized Controlled Trial

Alexandria University0 sites32 target enrollmentStarted: January 1, 2025Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Status
Recruiting
Enrollment
32
OverviewStudy DesignEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Overview

Brief Summary

Temporomandibular disorder (TMD) is a common condition with multifactorial etiology, including trauma, emotional stress, parafunctional habits, and occlusal discrepancies. TMD may be classified as myogenous, involving the masticatory and cervical muscles, or arthrogenous, affecting the temporomandibular joint structures. Management approaches range from noninvasive to invasive methods. The intraoral stabilization appliance (SA) is a widely used noninvasive treatment, while the ear stent (ES) has recently been introduced for managing myogenous TMD.

Aim: This randomized clinical trial aims to compare the effectiveness of SA and ES in the management of myogenous TMD.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Participants presenting with pain score grading at least 4 out of 10 on NRS.
  • •Participants with fully dentate type I occlusion.
  • •Patients experiencing no neurological disorders.

Exclusion Criteria

  • •Patients with arthrogenous TMJ will be excluded by Magnetic Resonance Imagining (MRI)
  • •Patients who have clicking or crepitation.
  • •Previous history of TMD treatment.
  • •History of recent trauma.
  • •The presence of systemic diseases (i.e., rheumatoid arthritis, osteoarthritis myologic or arthrological disease).
  • •Vascular disease (migraine and hypertension).
  • •Participants with uncontrolled systemic disease (diabetes), hematologic or neurologic disorders or inflammatory diseases.
  • •Patients who: Underwent trigger point myofascial injection, intramuscular stimulation, or dry needling in the last six months or Underwent neck and/or shoulder surgery in the last year.

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials

Completed
Not Applicable
Effect of Active Mandibular Techniques and Specific Cranio-cervical Therapeutic Exercise in Patients With Temporomandibular Disorders and Bruxism (AMaCe-TB)
NCT07303361Instituto de Investigación Biomédica de Salamanca60
Recruiting
Not Applicable
Effects of Mulligan Mobilization in Comparison With Maitland Mobilization in Temporomandibular Joint Dysfunction.
NCT07328269Foundation University Islamabad30
Not yet recruiting
Not Applicable
Effects of a Biopsychosocial Approach Added to Physiotherapy in Temporomandibular Disorders
NCT07320144Betül Özata40
Recruiting
Not Applicable
Effects Exercises in Temporomandibular Joint Disorders on Pain, Joint and Tongue Functions
NCT07304557Tayfun ISIK48
Unknown
Not Applicable
Digitally Trained Applied Relaxation for Treatment of Temporomandibular Pain
NCT07129096University of Oulu124